KM	Rattus norvegicus	0.067	acetyl-CoA	*
KM	Homo sapiens	0.0712	acetyl-CoA	*total membrane fractions of mesangial cells
KM	Mus musculus	0.0824	acetyl-CoA	*apparent KM
KM	Sus scrofa	0.11	acetyl-CoA	*
KM	Rattus norvegicus	0.137	acetyl-CoA	*
KM	Oryctolagus cuniculus	0.146	acetyl-CoA	*microsomal fraction
KM	Rattus norvegicus	0.173	acetyl-CoA	*
KM	Oryctolagus cuniculus	0.214	acetyl-CoA	*neuronal nuclear fraction
KM	Rattus norvegicus	0.274	acetyl-CoA	*Km is induced to 0.118 mM in presence of Ca2+
KM	Rattus norvegicus	0.046	butyryl-CoA	*
KM	Rattus norvegicus	0.128	propionyl-CoA	*
KM	Rattus norvegicus	0.02	hexanoyl-CoA	*
KM	Oryctolagus cuniculus	0.018	1-alkyl-sn-glycero-3-phosphocholine	*
KM	Mus musculus	0.1282	1-O-hexadecyl-sn-glycero-3-phosphocholine	*apparent KM
KM	Homo sapiens	0.00921	lyso-platelet-activating factor	*total membrane fractions of mesangial cells
KM	Oryctolagus cuniculus	0.009	1-alkyl-sn-glycero-3-phosphate	*
KM	Oryctolagus cuniculus	0.011	1-acyl-sn-glycero-3-phosphate	*
MW	Rattus norvegicus	29000	*	*x * 29000, SDS-PAGE and affinity labelling experiments
MW	Mus musculus	60000	*	*determined by SDS-PAGE and Western Blot analysis
MW	Rattus norvegicus	800000	*	*MW after gel filtration, aggregate of several proteins or protein aggregates coated with lipids
PATH	*	Ether lipid metabolism	*	*
PATH	*	Metabolic pathways	*	*
SA	Canis lupus familiaris	-999	*	*
SA	Rattus norvegicus	-999	*	*
SA	Homo sapiens	-999	*	*influence of phospholipids on specific activity at 37&deg;C
SA	Oryctolagus cuniculus	-999	*	*
SA	Homo sapiens	-999	*	*exogenous addition of lyso-platelet-activating factor (PAF) without effect on acetyltransferase activity, block of enzyme activity by a tyrosine kinase inhibitor and a calmodulin antagonist in H2O2-stimulated cells suggests involvement of tyrosine kinase and calcium/calmodulin-dependent protein kinase in regulation of enzyme activity
SA	Mus musculus	-999	*	*transcript level and enzyme activity elevated in spinal cord of experimental allergic encephalomyelitis (EAE) mice, correlation with disease severity, accumulation of platelet-activating factor dependent on the group IVA cytosolic PLA2/LysoPAFAT present in infiltrating macrophages and activated microglia
SA	Homo sapiens	-999	*	*specific activity of 32.4%, 1.7 ng/microl Tenofovir-DF in the cell incubation medium of HMC; specific activity of 76.2%, 1.9 ng/microl Lopinavir-r in the cell incubation medium of HMC
SA	Homo sapiens	0.0000041	*	*median activity of lyso-PAF-acetyltransferase in leukocyte homogenates of patients with heart failure
SA	Mus musculus	0.000017	*	*brain, Ca2+ independent lyso-PAF AT activity in the presence of EDTA, in the presence of Ca2+ 0.000104
SA	Mus musculus	0.000104	*	*spleen, Ca2+ independent lyso-PAF AT activity in the presence of EDTA, in the presence of Ca2+ 0.000470
SA	Rattus norvegicus	0.0002	*	*kidney cortex; liver
SA	Mus musculus	0.00033	*	*lung, Ca2+ independent lyso-PAF AT activity in the presence of EDTA, in the presence of Ca2+ 0.000452
SA	Rattus norvegicus	0.0004	*	*liver specific activity is reduced in presence of dexamethasone and medroxyprogesterone
SA	Rattus norvegicus	0.001	*	*spleen specific activity is reduced in presence of dexamethasone
SA	Rattus norvegicus	0.002	*	*kidney medulla
SA	Rattus norvegicus	0.0021	*	*A23187 stimulated cell
SA	Rattus norvegicus	0.0026	*	*bone marrow
SA	Rattus norvegicus	0.0039	*	*lymph nodes
SA	Rattus norvegicus	0.004	*	*lung; thymus
SA	Rattus norvegicus	0.01	*	*spleen microsome
SA	Rattus norvegicus	0.317	*	*
